Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.73 USD | -0.51% | +4.51% | +0.31% |
Financials (USD)
Sales 2024 * | 206M | Sales 2025 * | 243M | Capitalization | 889M |
---|---|---|---|---|---|
Net income 2024 * | 19M | Net income 2025 * | 30M | EV / Sales 2024 * | 4.05 x |
Net cash position 2024 * | 56.09M | Net cash position 2025 * | 92.97M | EV / Sales 2025 * | 3.27 x |
P/E ratio 2024 * |
79.4
x | P/E ratio 2025 * |
47
x | Employees | 1,102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.33% |
Latest transcript on Enfusion, Inc.
1 day | -0.51% | ||
1 week | +4.51% | ||
Current month | +4.51% | ||
1 month | +1.35% | ||
3 months | +22.70% | ||
6 months | +13.14% | ||
Current year | +0.31% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 05-12-31 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 22-12-18 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 21-12-06 |
Brad Bernstein
BRD | Director/Board Member | 57 | 20-12-31 |
Director/Board Member | 63 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +8.42% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 9.73 | -0.51% | 259,873 |
24-05-06 | 9.78 | +2.19% | 421,891 |
24-05-03 | 9.57 | +0.53% | 255,937 |
24-05-02 | 9.52 | +0.11% | 237,455 |
24-05-01 | 9.51 | +2.15% | 261,604 |
Delayed Quote Nyse, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.31% | 889M | |
+8.86% | 3,074B | |
+6.74% | 83.22B | |
+4.28% | 77.61B | |
+24.64% | 56.14B | |
-14.03% | 52.63B | |
-22.59% | 47.31B | |
+24.57% | 44.65B | |
+60.89% | 37.98B | |
-11.33% | 25.66B |
- Stock Market
- Equities
- ENFN Stock